The Board of Directors of Panacea Biotec Limited has at its meeting held today 13.11.2024 inter-alia considered and approved:1. Unaudited Standalone and Consolidated Financial Results (Provisional) for the quarter and half year ended 30.09.2024;2. Raising of funds by way of External Commercial Borrowings of an amount upto US$ 20 million (equivalent to ~Rs.168.16 Crore) from the U.S. International Development Finance Corporation;3.Appointment of Mr. Rajesh Jain Chartered Accountant as an additional director in the capacity of non-executive Independent Director for a term of 5 years w.e.f. 13.11.2024 subject to the approval of the shareholders; and4. Re-appointment of Dr. Rajesh Jain as Chairman and Managing Director liable to retire by rotation for a term of 3 years with effect from January 01 2025 subject to the approval of the shareholders.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
